Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

The sub-classification of type B2 vessels according to the magnifying endoscopic classification of the Japan Esophageal Society.

Tanaka I, Hirasawa D, Saito H, Matsuda T, Nakahori M, Maeda Y, Okuzono T, Suzuki K, Igarashi K, Nawata Y, Ito S, Unno S, Chonan A.

Dig Endosc. 2020 Jan;32(1):49-55. doi: 10.1111/den.13459. Epub 2019 Aug 20.

PMID:
31177563
2.

Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.

Nawata Y, Yamaguchi T, Fukumori R, Yamamoto T.

Int J Neuropsychopharmacol. 2019 Feb 1;22(2):165-172. doi: 10.1093/ijnp/pyy086.

3.

Lysozyme Mutants Accumulate in Cells while Associated at their N-terminal Alpha-domain with the Endoplasmic Reticulum Chaperone GRP78/BiP.

Kamada Y, Nawata Y, Sugimoto Y.

Int J Biol Sci. 2016 Jan 1;12(2):184-97. doi: 10.7150/ijbs.13710. eCollection 2016.

4.

Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.

Nawata Y, Kitaichi K, Yamamoto T.

Drug Alcohol Depend. 2016 Mar 1;160:76-81. doi: 10.1016/j.drugalcdep.2015.12.016. Epub 2015 Dec 30.

PMID:
26796595
5.

Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity-results from the ENCOURAGE study, a prospective, international, multicenter randomized study.

Yamanaka H, Nagaoka S, Lee SK, Bae SC, Kasama T, Kobayashi H, Nishioka Y, Ueki Y, Seto Y, Nishinarita M, Tamura N, Kimura N, Saito K, Tomita T, Nawata Y, Suzuki S, Ishigatsubo Y, Munakata Y, Makino Y, Inoue E, Tanaka Y, Takeuchi T; ENCOURAGE study group.

Mod Rheumatol. 2016 Sep;26(5):651-61. doi: 10.3109/14397595.2015.1123349. Epub 2015 Dec 23.

PMID:
26698929
6.

Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors.

Yasuda Y, Arakawa T, Nawata Y, Shimada S, Oishi S, Fujii N, Nishimura S, Hattori A, Kakeya H.

Bioorg Med Chem. 2015 Apr 15;23(8):1776-87. doi: 10.1016/j.bmc.2015.02.038. Epub 2015 Feb 25.

PMID:
25773014
7.

Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood mononuclear cells using genome-wide DNA microarray.

Sanayama Y, Ikeda K, Saito Y, Kagami S, Yamagata M, Furuta S, Kashiwakuma D, Iwamoto I, Umibe T, Nawata Y, Matsumura R, Sugiyama T, Sueishi M, Hiraguri M, Nonaka K, Ohara O, Nakajima H.

Arthritis Rheumatol. 2014 Jun;66(6):1421-31. doi: 10.1002/art.38400.

8.

Retrospective study of technical aspects and complications of endoscopic submucosal dissection for large superficial colorectal tumors.

Nawata Y, Homma K, Suzuki Y.

Dig Endosc. 2014 Jul;26(4):552-5. doi: 10.1111/den.12217. Epub 2014 Jan 9.

PMID:
24405078
9.

Endoscopic mucosal resection with circumferential mucosal incision of duodenal carcinoid tumors.

Otaki Y, Homma K, Nawata Y, Imaizumi K, Arai S.

World J Gastrointest Endosc. 2013 Apr 16;5(4):197-200. doi: 10.4253/wjge.v5.i4.197.

10.

Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.

Watanabe K, Sakai R, Koike R, Sakai F, Sugiyama H, Tanaka M, Komano Y, Akiyama Y, Mimura T, Kaneko M, Tokuda H, Iso T, Motegi M, Ikeda K, Nakajima H, Taki H, Kubota T, Kodama H, Sugii S, Kuroiwa T, Nawata Y, Shiozawa K, Ogata A, Sawada S, Matsukawa Y, Okazaki T, Mukai M, Iwahashi M, Saito K, Tanaka Y, Nanki T, Miyasaka N, Harigai M.

Mod Rheumatol. 2013 Nov;23(6):1085-93. doi: 10.1007/s10165-012-0796-5. Epub 2012 Dec 5.

PMID:
23212592
11.

[Successful use of danaparoid in the treatment of portal vein thrombosis that developed in a warfarin-administered hepatitis C virus-related cirrhosis patient].

Nawata Y, Hamada K, Tajima H, Nishino N, Nakazawa T, Tobayashi K, Saitoh S.

Nihon Shokakibyo Gakkai Zasshi. 2012 Aug;109(8):1394-400. Japanese.

PMID:
22863964
12.
13.

Increases of CRF in the amygdala are responsible for reinstatement of methamphetamine-seeking behavior induced by footshock.

Nawata Y, Kitaichi K, Yamamoto T.

Pharmacol Biochem Behav. 2012 Apr;101(2):297-302. doi: 10.1016/j.pbb.2012.01.003. Epub 2012 Jan 12.

PMID:
22252103
14.

[Stimulative role of corticotropin-releasing factor in methamphetamine-seeking behavior induced by footshock].

Nawata Y, Kitaichi K, Yamamoto T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Apr;31(2):73-5. Japanese. No abstract available.

PMID:
21870363
15.

Efficacy and safety of ketoprofen patch in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.

Kawai S, Uchida E, Kondo M, Ohno S, Obata J, Nawata Y, Sugimoto K, Oribe M, Nagaya I.

J Clin Pharmacol. 2010 Oct;50(10):1171-9. doi: 10.1177/0091270009355813. Epub 2010 Feb 4.

PMID:
20133510
16.

A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.

Hiranita T, Yamamoto T, Nawata Y.

Neuroscience. 2010 Jan 20;165(2):300-12. doi: 10.1016/j.neuroscience.2009.10.055.

PMID:
19883738
17.

A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).

Nawata Y, Hiranita T, Yamamoto T.

Neuropsychopharmacology. 2010 Jan;35(2):515-20. doi: 10.1038/npp.2009.158.

18.

Methamphetamine-seeking behavior is due to inhibition of nicotinic cholinergic transmission by activation of cannabinoid CB1 receptors.

Hiranita T, Nawata Y, Sakimura K, Yamamoto T.

Neuropharmacology. 2008 Dec;55(8):1300-6. doi: 10.1016/j.neuropharm.2008.08.012. Epub 2008 Aug 22.

PMID:
18782581
19.

[Drug self-administration methods to the study of drug craving (drug seeking behavior)].

Nawata Y, Yamamoto T.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2008 Jun;43(3):158-65. Review. Japanese.

PMID:
18646641
20.

Suppression of methamphetamine-seeking behavior by nicotinic agonists.

Hiranita T, Nawata Y, Sakimura K, Anggadiredja K, Yamamoto T.

Proc Natl Acad Sci U S A. 2006 May 30;103(22):8523-7. Epub 2006 May 22.

21.

Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis.

Kurasawa K, Nawata Y, Takabayashi K, Kumano K, Kita Y, Takiguchi Y, Kuriyama T, Sueishi M, Saito Y, Iwamoto I.

Clin Exp Immunol. 2002 Sep;129(3):541-8.

22.

Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment.

Oinuma K, Harada Y, Nawata Y, Takabayashi K, Abe I, Kamikawa K, Moriya H.

Ann Rheum Dis. 2001 Dec;60(12):1145-8.

23.

Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.

Oishi Y, Sumida T, Sakamoto A, Kita Y, Kurasawa K, Nawata Y, Takabayashi K, Takahashi H, Yoshida S, Taniguchi M, Saito Y, Iwamoto I.

J Rheumatol. 2001 Feb;28(2):275-83.

PMID:
11246661
24.

[Central nervous system involvement in systemic lupus erythematosus].

Nawata Y, Takabayashi K, Kurasawa K, Iwamoto I, Saito Y.

Nihon Rinsho Meneki Gakkai Kaishi. 2000 Dec;23(6):666-9. Japanese. No abstract available.

PMID:
11210766
25.

Increased interleukin-17 production in patients with systemic sclerosis.

Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y, Takabayashi K, Iwamoto I.

Arthritis Rheum. 2000 Nov;43(11):2455-63.

26.

Sustained hemostatic abnormality in patients with steroid-induced osteonecrosis in the early period after high-dose corticosteroid therapy.

Oinuma K, Harada Y, Nawata Y, Takabayashi K, Abe I, Kamikawa K, Moriya H.

J Orthop Sci. 2000;5(4):374-9.

PMID:
10982687
27.

[Case of recurrent subglottic stenosis later followed by the development of Wegener's granulomatosis].

Sano H, Kita Y, Nawata Y, Tsukahara Y, Kurasawa K, Takabayashi K, Iwamoto I, Saito Y.

Nihon Naika Gakkai Zasshi. 1999 Dec 10;88(12):2469-70. Japanese. No abstract available.

PMID:
10630009
28.

Saccharomyces cerevisiae cultured under aerobic and anaerobic conditions: air-level oxygen stress and protection against stress.

Ohmori S, Nawata Y, Kiyono K, Murata H, Tsuboi S, Ikeda M, Akagi R, Morohashi KI, Ono B.

Biochim Biophys Acta. 1999 Nov 16;1472(3):587-94.

PMID:
10564773
29.

Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.

Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I.

J Rheumatol. 1999 Jul;26(7):1527-33.

PMID:
10405940
30.

Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms.

Komatsu N, Kodama K, Yamanouchi N, Okada S, Noda S, Nawata Y, Takabayashi K, Iwamoto I, Saito Y, Uchida Y, Ito H, Yoshikawa K, Sato T.

Eur Neurol. 1999 Jul;42(1):41-8.

PMID:
10394047
31.

[Case of lupus cystitis diagnosed in the early stage].

Uchida H, Takabayashi K, Nawata Y, Oishi Y, Inaba M, Kita Y, Kurasawa K, Iwamoto I, Saito Y, Matsumura R.

Nihon Naika Gakkai Zasshi. 1998 Jul 10;87(7):1379-81. Japanese. No abstract available.

PMID:
9745291
32.

[Vertical oculomotor disorders in progressive supranuclear palsy and spino-cerebellar degeneration].

Nawata Y, Furukawa T, Watanabe M, Kanoh A.

Nihon Jibiinkoka Gakkai Kaiho. 1997 Jul;100(7):770-81. Japanese.

PMID:
9277099
33.

Osteonecrosis of the femoral head: a prospective study with MRI.

Sakamoto M, Shimizu K, Iida S, Akita T, Moriya H, Nawata Y.

J Bone Joint Surg Br. 1997 Mar;79(2):213-9.

PMID:
9119845
34.

[Coping with intractable femur head necrosis in patients with collagen diseases].

Harada Y, Iida S, Ikenoue S, Nawata Y, Takabayashi K, Shimizu K, Sakamoto M, Moriya H.

Nihon Naika Gakkai Zasshi. 1996 Nov 10;85(11):1882-8. Japanese. No abstract available.

PMID:
9019511
35.

[Coping with pathological changes in heart and lung in collagen diseases--dermatomyositis and interstitial pneumonia].

Nawata Y.

Nihon Naika Gakkai Zasshi. 1996 Nov 10;85(11):1850-4. Review. Japanese. No abstract available.

PMID:
9019505
36.

[Lupus anticoagulants in patients with systemic lupus erythematosus].

Matsuura Y, Nawata Y, Miike S, Hiraguri M, Kita Y, Kurasawa K, Takabayashi K, Oh H, Iwamoto I, Saito Y.

Ryumachi. 1996 Feb;36(1):16-24. Japanese.

PMID:
8711533
37.

Investigation of EB virus and cytomegalovirus in rapidly progressive interstitial pneumonitis in polymyositis/dermatomyositis by in situ hybridization and polymerase chain reaction.

Hashimoto Y, Nawata Y, Kurasawa K, Takabayashi K, Oda K, Mikata A, Iwamoto I.

Clin Immunol Immunopathol. 1995 Dec;77(3):298-306.

PMID:
7586740
38.

Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms.

Kodama K, Okada S, Hino T, Takabayashi K, Nawata Y, Uchida Y, Yamanouchi N, Komatsu N, Ikeda T, Shinoda N, et al.

J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):307-11.

39.

[Effects of fluconazole on onychomycosis in the patients with collagen diseases].

Takabayashi K, Nawata Y, Sumida T, Izumi H, Otawa M, Iwamoto I, Tanabe E, Tomioka H, Sugiyama T, Sueishi M.

Ryumachi. 1995 Feb;35(1):72-6. Japanese.

PMID:
7732493
40.

[Thrombotic thrombocytopenic purpura (TTP) observed in a patient with primary antiphospholipid antibody syndrome].

Umibe T, Nawata Y, Mori N, Kanai H, Takabayashi K, Iwamoto I, Yoshida S, Tomioka H.

Ryumachi. 1994 Dec;34(6):981-7. Japanese.

PMID:
7863389
41.

[Hemophagocytic syndrome observed in a patient with systemic lupus erythematosus].

Hayashi S, Nawata Y, Takabayashi K, Iwamoto I, Yoshida S.

Ryumachi. 1994 Aug;34(4):779-85. Japanese.

PMID:
7974030
42.

HLA-DR alleles in patients with Sjögren's syndrome over-representing V beta 2 and V beta 13 genes in the labial salivary glands.

Sumida T, Sakamaki T, Yonaha F, Maeda T, Namekawa T, Nawata Y, Takabayashi K, Iwamoto I, Yoshida S.

Br J Rheumatol. 1994 May;33(5):420-4.

PMID:
8173843
43.

Chronic salicylate intoxication and rhabdomyolysis in a patient with scleroderma and Sjögren's syndrome.

Nawata Y, Kagami M, Nakajima H, Matsumura R, Sugiyama T, Sueishi M, Hirasawa H, Iwamoto I, Yoshida S.

J Rheumatol. 1994 Feb;21(2):357-9.

PMID:
8182651
44.

Cytokines mediating the proliferation and differentiation of B-1 lymphocytes and their role in ontogeny and phylogeny.

Allison AC, Nawata Y.

Ann N Y Acad Sci. 1992 May 4;651:200-19. Review. No abstract available.

PMID:
1376040
45.
46.

Structure of thiolactomycin.

Nawata Y, Sasaki H, Oishi H, Suzuki K, Sawada M, Ando K, Iitaka Y.

Acta Crystallogr C. 1989 Jun 15;45 ( Pt 6):978-9.

PMID:
2610986
47.

Prevalence and role of IgG anti-IgE autoantibody in allergic disorders.

Koike T, Tsutsumi A, Nawata Y, Tomioka H, Yoshida S.

Monogr Allergy. 1989;26:165-75. No abstract available.

PMID:
2788811
48.
49.

Relationship between anti-IgE autoantibody and severity of bronchial asthma.

Iwamoto I, Nawata Y, Koike T, Tanaka M, Tomioka H, Yoshida S.

Int Arch Allergy Appl Immunol. 1989;90(4):414-6.

PMID:
2693362
50.

Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice.

Ichikawa K, Shimada K, Nawata Y, Ishii T, Tomioka H, Yoshida S, Koike T.

Clin Exp Immunol. 1988 Oct;74(1):110-4.

Supplemental Content

Loading ...
Support Center